Verdane Invests in Clue to Accelerate the Future of Women’s Health

Contributed by: GlobeNewswire

Tags

Health

More Like This

Clue Reaches 1 Million Paid Subscribers, Cementing Position as Leading Data-Driven Women's Health Intelligence Platform

Clue Expands Wearable Integrations with Withings, Ultrahuman, WHOOP, Huawei, Polar, Fitbit, Noise and Luna, Unlocking Deeper Insights into Women’s Health

Clue Launches "Connect the Dots" Campaign for Mental Health Awareness Month, Highlighting the Critical Link Between Menstrual Cycles and Mental Wellbeing

Clue Unveils Our Year In Cycles: A Candid Look at How We Bled, Felt, Loved and Lived in 2025

NHS-licensed healthcare platform Evaro partners with period tracking app Clue in UK-first integration

EQT to acquire majority position to support the growth of CluePoints, a leading provider of AI-powered software solutions used for data interrogation and analytics in clinical trials

Sebastian Wintgens, Principal, Verdane; John Byrne, CEO and Founder, Corlytics; Simon Russell, Chair, Corlytics. (Photo: Business Wire)

Global RegTech Software Consolidator Corlytics Receives Significant Investment Backing From Verdane to Continue Category Leadership

PR Newswire associated0

Clue ARR more than tripled from Series A in 2021